Skip to main content
Review article

COVID-19 Heart Lesions in Children: Clinical, Diagnostic and Immunological Changes

Е. С. ВасичкинаAlmazov National Medical Research Centre, 197341 St. Petersburg, RussiaD. Yu. AlekseevaAlmazov National Medical Research Centre, 197341 St. Petersburg, RussiaIgor KudryavtsevInstitute of Experimental Medicine, 197341 St. Petersburg, RussiaAnzhela GlushkovaV.M. Bekhterev National Research Medical Center for Psychiatry and Neurology, 192019 St. Petersburg, RussiaAnastasia Y. StarshinovaAlmazov National Medical Research Centre, 197341 St. Petersburg, RussiaAnastasia Y. StarshinovaAlmazov National Medical Research Centre, 197341 St. Petersburg, RussiaАнна МалковаFaculty of Natural Sciences, Ariel University, Ariel 40700, IsraelD.А. KudlаyNRC Institute of Immunology FMBA of Russia, 115478 Moscow, RussiaАнна СтаршиноваAlmazov National Medical Research Centre, 197341 St. Petersburg, Russia
2023en
ABI

Abstract

In the beginning of COVID-19, the proportion of confirmed cases in the pediatric population was relatively small and there was an opinion that children often had a mild or asymptomatic course of infection. Our understanding of the immune response, diagnosis and treatment of COVID-19 is highly oriented towards the adult population. At the same time, despite the fact that COVID-19 in children usually occurs in a mild form, there is an incomplete understanding of the course as an acute infection and its subsequent manifestations such as Long-COVID-19 or Post-COVID-19, PASC in the pediatric population, correlations with comorbidities and immunological changes. In mild COVID-19 in childhood, some authors explain the absence of population decreasing T and B lymphocytes. Regardless of the patient's condition, they can have the second phase, related to the exacerbation of inflammation in the heart tissue even if the viral infection was completely eliminated-post infectious myocarditis. Mechanism of myocardial dysfunction development in MIS-C are not fully understood. It is known that various immunocompetent cells, including both resident inflammatory cells of peripheral tissues (for example macrophages, dendritic cells, resident memory T-lymphocytes and so on) and also circulating in the peripheral blood immune cells play an important role in the immunopathogenesis of myocarditis. It is expected that hyperproduction of interferons and the enhanced cytokine response of T cells 1 and 2 types contribute to dysfunction of the myocardium. However, the role of Th1 in the pathogenesis of myocarditis remains highly controversial. At the same time, the clinical manifestations and mechanisms of damage, including the heart, both against the background and after COVID-19, in children differ from adults. Further studies are needed to evaluate whether transient or persistent cardiac complications are associated with long-term adverse cardiac events.

Identifiers

Citations and references

Cited by 20 references